Axtria is a business services company based in the United States, specializing in custom software and IT services, particularly within the life sciences sector. Founded in 2010, the company provides enterprise-grade analytics and integrated software technologies aimed at enhancing patient outcomes by effectively connecting therapies with patients. Axtria's expertise is underscored by its focus on generative artificial intelligence (GenAI), as highlighted in its recent publications. The company outlines a seven-dimensional framework for implementing GenAI to drive significant value in pharmaceutical research and commercialization. This framework emphasizes the importance of aligning GenAI initiatives with strategic business objectives, particularly the need for executive support and demonstrated value before broader adoption. Additionally, Axtria has contributed to discussions on the evolution of pharma field force deployment and targeting, reflecting its commitment to advancing data-driven solutions in the industry. Through its research articles and case studies, Axtria aims to address critical challenges and opportunities in the life sciences market, reinforcing its role as a key player in the intersection of technology and healthcare.